Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Dirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, Gayane Melikyan, Hassan Al Hail, Lubna El-Sheikh, Musab Ali, Hassan Al Hussein, Faiza Ibrahim & Yolande Hanssens. (2019) Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview. Current Medical Research and Opinion 35:2, pages 249-260.
Read now
Read now
Eman J. Abdullah & Hanan E. Badr. (2018) Assessing the quality of life in patients with multiple sclerosis in Kuwait: a cross sectional study. Psychology, Health & Medicine 23:4, pages 391-399.
Read now
Read now
Sherif M Hamdy, Maged Abdel-Naseer, Nevin M Shalaby, Alaa N Elmazny, Ahmed A Nemr, Amr Hassan, Mohamed I Hegazy, Husam S Mourad, Nirmeen A Kishk, Mona A Nada, Ahmed Abdelalim, Amr M Fouad & Hatem S Shehata. (2017) Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study. Neuropsychiatric Disease and Treatment 13, pages 1895-1903.
Read now
Read now
Dirk Deleu, Boulenouar Mesraoua, Hisham El Khider, Beatriz Canibano, Gayane Melikyan, Hassan Al Hail, Noha Mhjob, Anjushri Bhagat, Faiza Ibrahim & Yolande Hanssens. (2017) Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar. Current Medical Research and Opinion 33:3, pages 439-458.
Read now
Read now
B. Yamout, R. Alroughani, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, M. Sahraian, S. Khoury, Z. Alkawi, S. Koussa, M. Zakaria, J. Al Khaburi, T. Alsaadi & S. Bohlega. (2015) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Current Medical Research and Opinion 31:7, pages 1349-1361.
Read now
Read now
Abdulrahman M. Al Tahan, Isa Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Abdulkader Daif, Dirk Deleu, Khaled Esmat, Dominic Giampaolo, Mark S. Freedman, Michael Gwilt, Hassan Hosny, Jihad S. Inshasi, Mohammed Aljumah, Ahmad Khalifa, Hossein Pakdaman, Miklós Szólics, Bassem I. Yamout, Mohammed A. Sahraian & Magd F. Zakaria. (2014) Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. International Journal of Neuroscience 124:9, pages 635-641.
Read now
Read now
R. Alroughani, A. Ashkanani & S. Lamdhade. (2012) Clinical Characteristics of Multiple Sclerosis in Kuwait: Data From the New MS Registry of Amiri Hospital. International Journal of Neuroscience 122:2, pages 82-87.
Read now
Read now
Articles from other publishers (52)
Gagana Mallawaarachchi, David J Rog & Joyutpal Das. (2024) Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis. Multiple Sclerosis and Related Disorders 81, pages 105153.
Crossref
Crossref
Maya Zeineddine, Amal Al-Hajje, Pascale Salameh, Anne Helme, Michael Gunnar Thor, Farid Boumediene & Bassem Yamout. (2023) Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based study. Multiple Sclerosis and Related Disorders 79, pages 104959.
Crossref
Crossref
Shady Safwat Hassan, Esam S. Darwish, Gellan K. Ahmed, Samah R. Azmy & Nourelhoda A. Haridy. (2023) Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
Crossref
Salma Al-Abri, Abdullah Al-Asmi, Sachin Jose & Arunodaya R Gujjar. (2023) Initial clinical and radiological features of patients with multiple sclerosis in Oman. Multiple Sclerosis and Related Disorders 75, pages 104734.
Crossref
Crossref
Zuber Khan, Ghanshyam Das Gupta & Sidharth Mehan. (2023) Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges. Journal of Clinical Medicine 12:13, pages 4274.
Crossref
Crossref
Esraa Q Alsaedi, Marwa Q Alsaedi & Farah A Mansuri. (2022) Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia. Cureus.
Crossref
Crossref
M. Abuawad, A. Ziyadeh-Isleem, A. Alkaiyat, J. Ziyadeh, B. Afifi, M. Saidi & A. Sous. (2022) Epidemiology of multiple sclerosis in West bank of Palestine. Multiple Sclerosis and Related Disorders 59, pages 103686.
Crossref
Crossref
Wafaa M. Farghaly, Heba M. Saad Eldien, Mohammed A. Sayed, Hassan M. Elnady, Ashraf Khodeary, Abdelhady R. Abdel-Gawad, Hamdy N. El-Tallawy, Mohammed G. Abdellatif & Hazem K. Alhewaig. (2021) The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57:1.
Crossref
Crossref
M. Alluqmani, W. Roda, M. Qqrmli, G. Blevins, F. Giuliani & C. Power. (2021) Differential disease phenotypes and progression in relapsing–remitting multiple sclerosis: comparative analyses of single Canadian and Saudi Arabian clinics. BMC Neurology 21:1.
Crossref
Crossref
Jihad S. Inshasi, Sarmed Alfahad, Taoufik Alsaadi, Ali Hassan, Tayseer Zein, Victoria Ann Mifsud, Suzan Ibrahim Nouri, Mustafa Shakra, Ahmed Osman Shatila, Miklos Szolics, Mona Thakre, Ajit Kumar & Amir Boshra. (2021) Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates. Neurology and Therapy 10:2, pages 435-454.
Crossref
Crossref
Saeed Bohlega, Ahmed Elboghdady, Awatef Al-Johani, Koshu Mahajan, Majdoline Khalil Mughari, Mai Al-Saqa’aby, Omneya Mohamed, Rola Alarieh & Yaser Al Malik. (2021) Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity–Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia. Value in Health Regional Issues 25, pages 189-195.
Crossref
Crossref
Ali Forouhari, Ghazale Taheri, Mehri Salari, Mahmood Moosazadeh & Masoud Etemadifar. (2021) Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 54, pages 103119.
Crossref
Crossref
Marwa Al-Senani, Abdullah Al-Salti, Ramachandiran Nandhagopal, Ibrahim Al-Zakwani, Jaber Alkhabouri, Mortadha Eltigani Elyas, Arunodaya R Gujjar & Abdullah Al-Asmi. (2021) Epidemiology of multiple sclerosis in the Sultanate of Oman: A hospital based study. Multiple Sclerosis and Related Disorders 53, pages 103034.
Crossref
Crossref
Maya Zeineddine, Amal Al Hajje, Ali Hussein, Nabil El Ayoubi & Bassem Yamout. (2021) Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east. Multiple Sclerosis and Related Disorders 52, pages 102963.
Crossref
Crossref
Samuele Bonomi, Shan Jin, William J. Culpepper & Mitchell T. Wallin. (2021) MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review. Multiple Sclerosis and Related Disorders 51, pages 102885.
Crossref
Crossref
Azra Zafar & Foziah Jabbar Gossab AlShamrani. (2021) No evidence of disease activity-3 (NEDA-3) status in patients with relapsing remitting multiple sclerosis: Evidence from Saudi cohort receiving mainly Interferon.. Multiple Sclerosis and Related Disorders 51, pages 102875.
Crossref
Crossref
Jihad Said Inshasi, Abubaker Almadani, Sarmad Al Fahad, Suzan Ibrahim Noori, Taoufik Alsaadi, Mustafa Shakra, Ahmed Osman Shatila, Tayseer Mohammed Zein & Amir Boshra. (2020) High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates. Neurodegenerative Disease Management 10:4, pages 257-266.
Crossref
Crossref
Masoud Etemadifar, Yalda Nikanpour, Amir Neshatfar, Marjan Mansourian & Sean Fitzgerald. (2020) Incidence and prevalence of multiple sclerosis in persian gulf area: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 40, pages 101959.
Crossref
Crossref
O Al Wutayd. (2019) Association of infections with multiple sclerosis in Gulf Cooperation Council countries: a review. Journal of International Medical Research 48:4, pages 030006051988415.
Crossref
Crossref
Maya M Zeineddine & Bassem I Yamout. (2020) Treatment of multiple sclerosis in special populations: The case of refugees. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:1, pages 205521731984846.
Crossref
Crossref
Bassem I Yamout, Wassim Assaad, Hani Tamim, Saloua Mrabet & Riyad Goueider. (2020) Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:1, pages 205521731984188.
Crossref
Crossref
Raed Alroughani, Bart Van Wijmeersch, Jabber Al Khaboori, Isa Ahmed Alsharoqi, Samar F. Ahmed, Ali Hassan, Jihad Inshasi, Derk W. Krieger, Mustafa Shakra, Ahmed Osman Shatila, Miklos Szolics, Mohamed Khallaf & Aly Ezzat. (2020) The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective. Therapeutic Advances in Neurological Disorders 13, pages 175628642095411.
Crossref
Crossref
M. Etemadifar, S. Ghourchian, F. Sabeti, M. Akbari, F. Etemadifar & M. Salari. (2020) The higher prevalence of multiple sclerosis among Iranian Georgians; new clues to the role of genetic factors. Revue Neurologique 176:1-2, pages 113-117.
Crossref
Crossref
B. Yamout, M. Sahraian, S. Bohlega, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, S. Khoury, M Alkhawajah, S. Koussa, J. Al Khaburi, A. Almahdawi, T. Alsaadi, E. Slassi, S Daodi, M. Zakaria & R. Alroughani. (2020) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. Multiple Sclerosis and Related Disorders 37, pages 101459.
Crossref
Crossref
Manzoor Ahmed, Ruqqiya Mir, Mustafa Shakra & Safana Al Fardan. (2019) Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging. Multiple Sclerosis International 2019, pages 1-6.
Crossref
Crossref
Steve SimpsonJr.Jr., Wendy Wang, Peter Otahal, Leigh Blizzard, Ingrid A F van der Mei & Bruce V Taylor. (2019) Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry 90:11, pages 1193-1200.
Crossref
Crossref
A. Hosseinzadeh, M.R. Baneshi, B. Sedighi, J. Kermanchi & A.A. Haghdoost. (2019) Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health 175, pages 138-144.
Crossref
Crossref
Milad Azami, Mohammad Hossein YektaKooshali, Masoumeh Shohani, Ali Khorshidi & Leily Mahmudi. (2019) Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis. PLOS ONE 14:4, pages e0214738.
Crossref
Crossref
Nicoline Schiess, Katherine Huether, Kathryn B. Holroyd, Faisal Aziz, Essam Emam, Tarek Shahrour, Miklos Szolics & Taoufik Alsaadi. (2019) Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates. International Journal of MS Care 21:1, pages 29-34.
Crossref
Crossref
Narges Karimi, Mahdi Fakhar & Masoud Keighobadi. (2019) The endosymbiotic role of intestinal helminths in multiple sclerosis: Promising probiotic hypothesis. Tropical Parasitology 9:2, pages 131.
Crossref
Crossref
Qasem AlAlwan, Fozan Al-Battat, Mohammed AlAlwan, Suhailah Hakami, Hisham Dossary & Abdullah AlAlwan. (2019) Retrospective analysis of the clinical and radiological manifestations of multiple sclerosis at a general governmental hospital in Al-Ahsa, Saudi Arabia. International Journal of Medicine in Developing Countries, pages 117-123.
Crossref
Crossref
Victor Rivera. (2018) Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines. Biomedicines 6:4, pages 112.
Crossref
Crossref
Fatima Y. Ismail, Eliza Gordon-Lipkin, Katherine Huether, Iain Blair, Miklós Szólics, Taoufik Alsaadi, Faisal Aziz, Jehan Suleiman & Nicoline Schiess. (2018) Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison. Journal of Child Neurology 33:6, pages 422-427.
Crossref
Crossref
Saima NazishRizwana ShahidAzra ZafarFoziah AlshamraniAbdullah Al SulaimanMajed AlabdaliDanah AljaafariEsraa Al WabariFahd A Alkhamis. (2018) Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia. Journal of Clinical Neurology 14:3, pages 359.
Crossref
Crossref
Masoud Etemadifar, Niyousha Sadeghpour, Kimia Nekouie, Mohammadmostafa Jahansouz, Mehri Salari & Mahboobeh Fereidan-Esfahani. (2017) Multiple sclerosis among Afghan immigrants in Isfahan, Iran. Multiple Sclerosis and Related Disorders 13, pages 52-57.
Crossref
Crossref
Magd Zakaria, Dina A. Zamzam, Mohamed A. Abdel Hafeez, Mahmoud S. Swelam, Shaimaa S. Khater, Mai F. Fahmy, Ayman Abdel Hady, Mohamed M. Fouad, Azza Abdel Nasser, Hany Aref & Mohsen Gadallah. (2016) Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt. Multiple Sclerosis and Related Disorders 10, pages 30-35.
Crossref
Crossref
Nicoline Schiess, Katherine Huether, Taghreed Fatafta, Kathryn C. Fitzgerald, Peter A. Calabresi, Iain Blair, Taoufik Alsaadi & Miklos Szolics. (2016) How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates. Multiple Sclerosis and Related Disorders 9, pages 73-79.
Crossref
Crossref
Eiman M.A. Mohammed. (2016) Multiple sclerosis is prominent in the Gulf states: Review. Pathogenesis 3:2, pages 19-38.
Crossref
Crossref
Mahmoud M. Allam, Mohamed M. EL-Hamady, A.A. Morad, M.K. Faheem & Badr A.E. Morsi. (2015) Some neuropsychiatric and MRI manifestations in patients with multiple sclerosis. Middle East Current Psychiatry 22:1, pages 44-56.
Crossref
Crossref
Raed A Alroughani, Hany M Aref, Saeed A Bohlega, Maurice P Dahdaleh, Imed Feki, Mohammed A Al Jumah, Muhammad Z Al-Kawi, Salam F Koussa, Mohamad A Sahraian, Isa A Alsharoqi & Bassem I Yamout. (2014) Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring. BMC Neurology 14:1.
Crossref
Crossref
R Alroughani, SF Ahmed, R Behbehani, R Khan, A Thussu, KJ Alexander, A Ashkanani, V Nagarajan & J Al-Hashel. (2013) Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Multiple Sclerosis Journal 20:5, pages 543-547.
Crossref
Crossref
Klaus Lauer. (2014) Notes on the Epidemiology of Multiple Sclerosis, with Special Reference to Dietary Habits. International Journal of Molecular Sciences 15:3, pages 3533-3545.
Crossref
Crossref
Raed Alroughani, S.F. Ahmed & J. Al-Hashel. (2014) Demographics and Clinical Characteristics of Multiple Sclerosis in Kuwait. European Neurology 72:3-4, pages 181-185.
Crossref
Crossref
Hani T. S. BenamerHani T. S. Benamer. 2014. Neurological Disorders in the Arab World. Neurological Disorders in the Arab World
149
166
.
Hani T. S. BenamerHani T. S. Benamer. 2014. Neurological Disorders in the Arab World. Neurological Disorders in the Arab World
25
73
.
Saeed Bohlega, Jihad Inshasi, Abdel Rahman Tahan, Abu Bakr Madani, Hussien Qahtani & Peter Rieckmann. (2013) Multiple sclerosis in the Arabian Gulf countries: a consensus statement. Journal of Neurology 260:12, pages 2959-2963.
Crossref
Crossref
Naser Sharafaddinzadeh, Ali Moghtaderi, Nastaran Majdinasab, Maryam Dahmardeh, Davood Kashipazha & Bita Shalbafan. (2013) The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs. Clinical Neurology and Neurosurgery 115:8, pages 1271-1275.
Crossref
Crossref
Dirk Deleu, Danial Mir, Ahmed Al Tabouki, Rim Mesraoua, Boulenouar Mesraoua, Naveed Akhtar, Hassan Al Hail, Atlantic D’souza, Gayane Melikyan, Yahia ZB Imam, Yasir Osman, Osama Elalamy, Tageldin Sokrab, Sadaat Kamran, Francisco Ruiz Miyares & Faiza Ibrahim. (2012) Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Multiple Sclerosis Journal 19:6, pages 816-819.
Crossref
Crossref
J.O. Fleming. (2013) Helminth therapy and multiple sclerosis. International Journal for Parasitology 43:3-4, pages 259-274.
Crossref
Crossref
Mohammed Aljumah, Raed Alroughani, I. Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Dirk Deleu, Khaled Esmat, Ahmad Khalifa, Mohammad A. Sahraian, Miklós Szólics, Abdulrahman AlTahan, Bassem I. Yamout, Peter Rieckmann & Abdulkader Daif. (2013) Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries. Multiple Sclerosis International 2013, pages 1-6.
Crossref
Crossref
Michal Siegel, Tamar Paperna, Izabella Lejbkowicz, Panayiota Petrou, Radi Shahien, Dimitrios Karussis, Idit Lavi, Sara Dishon, Hanna Rawashdeh & Ariel Miller. (2012) Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel. Multiple Sclerosis Journal 18:12, pages 1737-1744.
Crossref
Crossref
R. Alroughani, J. Al Hashel, S. Lamdhade & S. F. Ahmed. (2012) Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria. ISRN Neurology 2012, pages 1-6.
Crossref
Crossref